Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study
European Journal of Neurology2022Vol. 29(6), pp. 1685–1696
Citations Over TimeTop 1% of 2022 papers
Verena Rass, Ronny Beer, Alois Josef Schiefecker, Anna Lindner, Mario Kofler, Bogdan‐Andrei Ianosi, Philipp Mahlknecht, Beatrice Heim, Marina Peball, Federico Carbone, Victoria Limmert, Philipp Kindl, Lauma Putnina, Elena Fava, Sabina Sahanic, Thomas Sonnweber, Wolfgang N. Löscher, Julia Wanschitz, Laura Zamarian, Atbin Djamshidian, Ivan Tancevski, Günter Weiß, Rosa Bellmann‐Weiler, Stefan Kiechl, Klaus Seppi, Judith Löffler‐Ragg, Bettina Pfausler, Raimund Helbok
Abstract
Our data indicate that a significant patient number still suffer from neurological sequelae including neuropsychiatric symptoms 1 year after COVID-19 calling for interdisciplinary management of these patients.
Related Papers
- → The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies(2003)379 cited
- → Dietary protein intake and risk of type 2 diabetes: results from the Melbourne Collaborative Cohort Study and a meta-analysis of prospective studies(2016)135 cited
- → Dairy intake and the risk of pancreatic cancer: the Japan Collaborative Cohort Study (JACC Study) and meta-analysis of prospective cohort studies(2021)11 cited
- → Dairy intake and the risk of pancreatic cancer: the Japan Collaborative Cohort Study (JACC Study) and meta-analysis of prospective cohort studies.(2022)7 cited